{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:37:11Z","timestamp":1761489431507},"reference-count":40,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives de P\u00e9diatrie"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.arcped.2014.02.005","type":"journal-article","created":{"date-parts":[[2014,8,11]],"date-time":"2014-08-11T12:46:04Z","timestamp":1407761164000},"page":"976-983","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Efficacit\u00e9 et tol\u00e9rance des immunoglobulines polyvalentes dans l\u2019hyperbilirubin\u00e9mie n\u00e9onatale par incompatibilit\u00e9 ABO. M\u00e9ta-analyse"],"prefix":"10.1016","volume":"21","author":[{"given":"A.","family":"Cortey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Elzaabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Waegemans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Roch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Aujard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcped.2014.02.005_bib0005","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.tracli.2005.02.001","article-title":"Incompatibilit\u00e9s f\u0153to-maternelles \u00e9rythrocytaires (IFME)\u00a0: de la surveillance immunoh\u00e9matologique des femmes enceintes \u00e0 la maladie h\u00e9molytique du nouveau-n\u00e9 (MHNN)","volume":"12","author":"Miquel","year":"2005","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.arcped.2014.02.005_bib0010","doi-asserted-by":"crossref","first-page":"F83","DOI":"10.1136\/adc.2005.076794","article-title":"Haemolytic disease of the newborn","volume":"92","author":"Murray","year":"2007","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.arcped.2014.02.005_bib0015","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.earlhumdev.2008.06.005","article-title":"The changing face of haemolytic disease of the newborn","volume":"84","author":"Roberts","year":"2008","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.arcped.2014.02.005_bib0020","first-page":"400","article-title":"Spectrum and outcome analysis of marked neonatal hyperbilirubinemia with blood group incompatibility","volume":"32","author":"Weng","year":"2009","journal-title":"Chang Gung Med J"},{"key":"10.1016\/j.arcped.2014.02.005_bib0025","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.arcped.2012.06.018","article-title":"Ict\u00e8re du nouveau-n\u00e9\u00a0: Le retour de l\u2019ict\u00e8re nucl\u00e9aire","volume":"19","author":"Cortey","year":"2012","journal-title":"Arch Pediatr"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.arcped.2014.02.005_bib0030","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/jp.2008.213","article-title":"A proposal to prevent severe neonatal hyperbilirubinemia and kernicterus","volume":"29","author":"Bhutani","year":"2009","journal-title":"J Perinatol"},{"key":"10.1016\/j.arcped.2014.02.005_bib0035","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1440-1754.2011.02217.x","article-title":"Severe neonatal jaundice: is it a rare event in Australia?","volume":"48","author":"McGillivray","year":"2012","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.arcped.2014.02.005_bib0040","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1542\/peds.2007-2915","article-title":"Trends in hospitalizations for neonatal jaundice and kernicterus in the United States, 1988\u20132005","volume":"123","author":"Burke","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.arcped.2014.02.005_bib0045","doi-asserted-by":"crossref","first-page":"F342","DOI":"10.1136\/adc.2006.105361","article-title":"Prospective surveillance study of severe hyperbilirubinaemia in the newborn in the UK and Ireland","volume":"92","author":"Manning","year":"2007","journal-title":"Arch Dis Child Fetal Neonatal"},{"key":"10.1016\/j.arcped.2014.02.005_bib0050","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1503\/cmaj.060328","article-title":"Incidence and causes of severe neonatal hyperbilirubinemia in Canada","volume":"175","author":"Sgro","year":"2006","journal-title":"CMAJ"},{"key":"10.1016\/j.arcped.2014.02.005_bib0055","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/08035250410022170","article-title":"Extreme hyperbilirubinaemia in term and near-term infants in Denmark","volume":"94","author":"Ebbesen","year":"2005","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.arcped.2014.02.005_bib0060","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1542\/peds.114.1.297","article-title":"Management of hyperbilirubinemia in the newborn infant 35\u00a0or more weeks of gestation","volume":"114","author":"American Academy of Pediatrics Subcommittee on Hyperbilirubinemia","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.arcped.2014.02.005_bib0065","series-title":"NICE clinical guideline 98: neonatal jaundice","author":"National Collaborating Centre for Women's and Children's Health","year":"2010"},{"key":"10.1016\/j.arcped.2014.02.005_bib0070","series-title":"Position statement: guidelines for detection, management and prevention of hyperbilirubinemia in term and late preterm newborn infants","author":"Barrington","year":"2007"},{"key":"10.1016\/j.arcped.2014.02.005_bib0075","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.arcped.2009.05.015","article-title":"High-dose intravenous immunoglobulin therapy and neonatal jaundice due to red blood cell alloimmunization","volume":"16","author":"Monpoux","year":"2009","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.arcped.2014.02.005_bib0080","first-page":"CD003313","article-title":"Immunoglobulin infusion for isoimmune haemolytic jaundice in neonates","volume":"3","author":"Alcock","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.arcped.2014.02.005_bib0085","doi-asserted-by":"crossref","first-page":"F6","DOI":"10.1136\/fn.88.1.F6","article-title":"Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn","volume":"88","author":"Gottstein","year":"2003","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.arcped.2014.02.005_bib0090","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration","author":"Higgins","year":"2009"},{"key":"10.1016\/j.arcped.2014.02.005_bib0095","first-page":"342","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"22","author":"Sterne","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.arcped.2014.02.005_bib0100","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1651-2227.1999.tb01085.x","article-title":"High-dose intravenous immunoglobulin therapy in neonatal immune haemolytic jaundice","volume":"88","author":"Alpay","year":"1999","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.arcped.2014.02.005_bib0105","first-page":"623","article-title":"[Intravenous immunoglobulin therapy for neonatal hyperbilirubinemia due to ABO or Rh incompatibility]","volume":"39","author":"Atici","year":"1996","journal-title":"Cocuk Sagligi Ve Hastaliklari Dergisi"},{"key":"10.1016\/j.arcped.2014.02.005_bib0110","first-page":"1350","article-title":"[Clinical study of early interventions for ABO hemolytic disease of the newborn]","volume":"26","author":"Huang","year":"2006","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"10.1016\/j.arcped.2014.02.005_bib0115","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/tropej\/47.1.50","article-title":"Multiple dose IVIG treatment in neonatal immune hemolytic jaundice","volume":"47","author":"Tanyer","year":"2001","journal-title":"J Trop Pediatr"},{"key":"10.1016\/j.arcped.2014.02.005_bib0120","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/jmf.16.3.163.166","article-title":"Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn","volume":"16","author":"Miqdad","year":"2004","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.arcped.2014.02.005_bib0125","first-page":"1827","article-title":"Intravenous immunoglobulin in ABO and Rh hemolytic diseases of newborn","volume":"27","author":"Nasseri","year":"2006","journal-title":"Saudi Med J"},{"key":"10.1016\/j.arcped.2014.02.005_bib0130","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.jclinepi.2010.02.005","article-title":"CONSORT 2010\u00a0statement: updated guidelines for reporting parallel group randomised trials","volume":"63","author":"Schulz","year":"2010","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.arcped.2014.02.005_bib0135","first-page":"w13593","article-title":"Treatment of immune thrombocytopenia with intravenous immunoglobulin and insights for other diseases. A historical review","volume":"142","author":"Imbach","year":"2012","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.arcped.2014.02.005_bib0140","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2165\/00063030-199708040-00003","article-title":"Intravenous immunoglobulin g therapy in fetal and neonatal alloimmune thrombocytopenia","volume":"8","author":"Dunsmore","year":"1997","journal-title":"BioDrugs"},{"key":"10.1016\/j.arcped.2014.02.005_bib0145","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1479-828X.2010.01270.x","article-title":"A review of pathophysiology and current treatment for neonatal alloimmune thrombocytopenia (NAIT) and introducing the Australian NAIT registry","volume":"51","author":"McQuilten","year":"2011","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.arcped.2014.02.005_bib0150","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1055\/s-0030-1263296","article-title":"Fetal and neonatal alloimmune thrombocytopenia: harvesting the evidence to develop a clinical approach to management","volume":"28","author":"Symington","year":"2011","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.arcped.2014.02.005_bib0155","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1111\/j.1651-2227.1996.tb13924.x","article-title":"Intravenous immune globulin in neonatal immune hemolytic disease: does it reduce hemolysis?","volume":"85","author":"Hammerman","year":"1996","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.arcped.2014.02.005_bib0160","first-page":"656","article-title":"[Meta-analysis of the effect of immunoglobulin infusion on neonatal isoimmune hemolytic disease caused by blood group incompatibility]","volume":"48","author":"Li","year":"2010","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"10.1016\/j.arcped.2014.02.005_bib0165","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/j.1651-2227.2009.01279.x","article-title":"Necrotizing enterocolitis following the use of intravenous immunoglobulin for haemolytic disease of the newborn","volume":"98","author":"Navarro","year":"2009","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.arcped.2014.02.005_bib0170","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1542\/peds.2009-0676","article-title":"Intravenous immunoglobulin and necrotizing enterocolitis in newborns with hemolytic disease","volume":"125","author":"Figueras-Aloy","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.arcped.2014.02.005_bib0175","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.arcped.2009.11.023","article-title":"Complications et recommandations d\u2019utilisation des immunoglobulines intraveineuses en cas de maladie h\u00e9molytique allo-immune du nouveau-n\u00e9","volume":"17","author":"Senterre","year":"2010","journal-title":"Arch Pediatr"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.arcped.2014.02.005_bib0180","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.tmrv.2007.01.001","article-title":"Guidelines on the use of intravenous immune globulin for hematologic conditions","volume":"21","author":"Anderson","year":"2007","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.arcped.2014.02.005_bib0185","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1111\/j.1651-2227.2008.00915.x","article-title":"Intravenous immune globulin reduces the need for exchange transfusions in Rhesus and ABO incompatibility","volume":"97","author":"Huizing","year":"2008","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.arcped.2014.02.005_bib0190","first-page":"93","article-title":"Adverse events associated with exchange transfusion and etiology of severe hyperbilirubinemia in near-term and term newborns","volume":"41","author":"B\u00fclb\u00fcl","year":"2011","journal-title":"Turk J Med Sci"},{"key":"10.1016\/j.arcped.2014.02.005_bib0195","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1542\/peds.99.5.e7","article-title":"Adverse events associated with exchange transfusion in healthy and ill newborns","volume":"99","author":"Jackson","year":"1997","journal-title":"Pediatrics"},{"key":"10.1016\/j.arcped.2014.02.005_bib0200","series-title":"R\u00e9f\u00e9rentiel immunoglobulines","author":"Agence national de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9","year":"2012"}],"container-title":["Archives de P\u00e9diatrie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X14000724?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X14000724?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T01:52:19Z","timestamp":1538358739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929693X14000724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0929693X14000724"],"URL":"https:\/\/doi.org\/10.1016\/j.arcped.2014.02.005","relation":{},"ISSN":["0929-693X"],"issn-type":[{"value":"0929-693X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacit\u00e9 et tol\u00e9rance des immunoglobulines polyvalentes dans l\u2019hyperbilirubin\u00e9mie n\u00e9onatale par incompatibilit\u00e9 ABO. M\u00e9ta-analyse","name":"articletitle","label":"Article Title"},{"value":"Archives de P\u00e9diatrie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcped.2014.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}